Safety, immunogenicity, and breakthrough infections during 1-year follow-up after COVISHIELD™ vaccination among healthcare workers in a teaching institute in North India: A prospective longitudinal study
Immunogenicity post-COVISHIELD™ vaccination increased after first and second doses but declined after 6 months and inclined after 1 year of the first dose. The safety profile was within acceptable limits.
Authors
- Madhu Kumari Gupta (ORCID: https://orcid.org/0000-0003-3877-9956)
- Ashish Bhalla (ORCID: https://orcid.org/0000-0001-5210-1012)
- Ritin Mohindra (ORCID: https://orcid.org/0000-0003-4224-898X)
- Sanjay Verma (ORCID: https://orcid.org/0000-0001-5064-2325)
- Mahesh Devnani (ORCID: https://orcid.org/0000-0002-5322-8733)
- Mini P. Singh (ORCID: https://orcid.org/0000-0001-6263-1850)
- Arnab Ghosh (ORCID: https://orcid.org/0000-0002-6049-7886)
- Indrakshi Sharma
- Vikas Suri
Institutions
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2025-02-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_935_24
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Postgraduate Institute of Medical Education and Research, Chandigarh